Brainlab, the digital medical technology company, unveiled Loop-X™, the first mobile intraoperative imaging robot today at NASS 2019 in Chicago. Loop-X sits at the core of the Brainlab Digital Surgery ...

Zimvie secured 510(k) clearance for its Vital Spinal Fixation System and instruments for use with Brainlab’s Spine & Trauma navigation software, positioning the company to co-market the products early ...

Brainlab and subsidiary Level Ex working closely with the AO to deliver extended reality technology for best practices in education and training MUNICH--(BUSINESS WIRE)--Brainlab, a digital medical ...

With Akili’s recent FDA clearance, healthcare video games have been making headlines. A Munich-based medical technology company recently acquired a different kind of game — one designed to help ...

Medical technology company Brainlab has acquired Level Ex, whose video games are used to train doctors to diagnose and treat COVID-19 and other health conditions. The outcome is a good one for Chicago ...

Digital surgery platform developer Brainlab is taking a leap into developing medical video games—designed not for patients, but for surgeons. The German maker of planning, navigation and robotic tools ...

MUNICH & REDWOOD CITY, Calif., February 25, 2026--(BUSINESS WIRE)--Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial ...

Earlier this year, ZimVie selected Brainlab to help achieve its goal of building out a comprehensive spinal surgery system through a partnership—rather than starting from scratch—and, so far, the ...

Brainlab has recalled the 3D navigation software used with the company's Spine & Trauma Navigation System due to the potential for inaccurate information to display that may prevent the surgeon from ...

Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial intelligence and sophisticated software algorithms, and Precision NeuroMed ...

The collaboration aims to standardize and scale the delivery planning of targeted therapies directly into brain tissue, overcoming long-standing limitations imposed by the blood-brain barrier, which ...